AI reads cancer markers: new model aims to standardize digestive tumor testing
NCT ID NCT07274579
First seen Dec 16, 2025 · Last updated May 14, 2026 · Updated 22 times
Summary
This study is developing an artificial intelligence model to automatically interpret CLDN18.2 protein levels in digestive system tumors. Researchers will use pathology samples from 2,000 patients to train and validate the AI, aiming to make testing more consistent and objective. The goal is to support precision medicine by improving how doctors diagnose and treat these cancers.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DIGESTIVE ONCOLOGY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Nanfang Hospital, Southern Medical University
Guangzhou, Guangdong, 510515, China
-
Qianfoshan Hospital
Jinan, Shandong, 250014, China
Conditions
Explore the condition pages connected to this study.